N-[2-(4-nitrophenoxy)ethyl]-2-(4-nitrophenyl)ethanamine | CAS:226992-13-8

We serve N-[2-(4-nitrophenoxy)ethyl]-2-(4-nitrophenyl)ethanamine CAS:226992-13-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
N-[2-(4-nitrophenoxy)ethyl]-2-(4-nitrophenyl)ethanamine

Chemical Name:N-[2-(4-nitrophenoxy)ethyl]-2-(4-nitrophenyl)ethanamine
CAS.NO:226992-13-8
Synonyms:N-[2-(4-nitrophenoxy)ethyl]-2-(4-nitrophenyl)ethanamine
[2-(4-nitrophenyl)ethyl]{2-[(4-nitrophenyl)oxy]ethyl}amine
N-[2-(p-nitrophenoxy)ethyl]-p-nitrophenethylamine
4-Nitro-N-[2-(4-nitrophenoxy)ethyl]benzeneethanamine
2-(4-nitrophenoxy)-N-[2-(4-nitrophenyl)ethyl]ethanamine
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 520.5±40.0 °C at 760 mmHg
Molecular Formula C16H17N3O5
Molecular Weight 331.323
Flash Point 268.6±27.3 °C
Vapour Pressure 0.0±1.4 mmHg at 25°C
Index of Refraction 1.603
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Dofetilide(CAS:115256-11-6).



Contact us for information like N-[2-(4-nitrophenoxy)ethyl]-2-(4-nitrophenyl)ethanamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(4-nitrophenoxy)-N-[2-(4-nitrophenyl)ethyl]ethanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-[2-(4-nitrophenoxy)ethyl]-2-(4-nitrophenyl)ethanamine Use and application,[2-(4-nitrophenyl)ethyl]{2-[(4-nitrophenyl)oxy]ethyl}amine technical grade,usp/ep/jp grade.


Related News: Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.4-Amino-3,5-dichloropyridine manufacturer The measure starts on February 4, according to South Korean Prime Minister Chung Sye-kyun.Tianeptine supplier Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely.5-Amino-2,3-dichloropyridine vendor “Out of an abundance of caution and based on the latest advice from leading health experts, we’re closing all our corporate offices, stores and contact centers in mainland China through February 9.”This leads to low numbers of one or more types of circulating blood cells, and to the need for blood transfusions. In MDS, some of the cells in the bone marrow are abnormal (dysplastic) and may have genetic abnormalities associated with them.